knowledge -WSS

knowledge

author：entertainment 2025-09-28 01:38:16 - browse：4

The home health industry lobbying group is suing Medicare over new payment cuts. But profits in the sector remain near all-time highs. Business Insider/AP

The National Association of Home Care and Hospice sued the Biden administration to halt the government’s recent proposed rule that would cut Medicare payments to home health agencies by 2.2% in 2024.

Since 2020, Medicare has updated its system for how it pays for home health, in particular by basing payments less on how much therapy someone is getting at home. By law, the new system can’t cost more or less than it otherwise would have, but Medicare reinforced this year that it had “paid more under the new system than it would have under the old system” — and thus continued cuts to home health for next year.

Newsletters

Sign up for STAT Health Care Inc.

Following the flow of money through the health care industry.

Please enter a valid email address. Privacy Policy

NAHC, the home health industry’s lobbying group, said in its lawsuit that Medicare has been violating the requirement to keep things “budget-neutral” and threatens to put home health operators out of business. But one thing NAHC failed to mention: Profits in the home health industry remain near all-time highs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

hotspot

WSS

Patient advocates sound warning on FDA proposal on salt intake

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

When women are denied an abortion, their children fare worse than peers

Chemotherapy drug shortage eases slightly but still widespread

Why age limits for politicians are a terrible idea

Evacuations in place as 3 wildfires burn in eastern Washington state

knowledge

knowledge

Sign up for STAT Health Care Inc.

leisure time

Medical records are filled with copy

FDA approves first treatment for ultra

Peter Hotez and the public health issue of online harassment

Congress must give Medicare recipients genetic counseling access

In Memoriam: Notable people who died in 2023

Cancer drug shortages' outsize impact on ovarian cancer patients

Psychedelics group wrestles with new pharma identity

FDA panel signals lack of confidence in Amgen cancer drug data

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

entertainment

Trump cancels press conference intended to dispute Georgia election interference charges

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Clinical trials must include more disabled people

Liz Cheney makes 1st public comment since Trump's election interference indictments

New definition of a human embryo proposed amid rapid advances

Was Amgen transparent enough on FDA's concern on cancer drug?

focus

hotspot

focus

focus